Amphastar Pharmaceuticals (AMPH) Current Assets (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Current Assets of $633.7 million for Q1 2026, up 7.78% year-over-year from $588.0 million in Q1 2025, and little changed quarter-over-quarter from $636.0 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Current Assets (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Current Assets history runs 14 years deep, the most recent figure standing at $633.7 million for Q1 2026.
- In Q1 2026, Current Assets rose 7.78% year-over-year to $633.7 million; the TTM figure through Mar 2026 stood at $633.7 million (up 7.78% YoY), while the FY2025 annual figure was $636.0 million, up 19.09% from the prior year.
- Current Assets for Q1 2026 stood at $633.7 million, roughly flat from $636.0 million in the prior quarter.
- The five-year high for Current Assets was $639.5 million in Q3 2025, with the low at $364.4 million in Q1 2022.
- The 5-year median for Current Assets is $534.1 million (2024), against an average of $501.4 million.
- The sharpest annual moves came in 2023 and 2024: Current Assets soared 41.33% in 2023, then gained 0.54% in 2024.
- Amphastar Pharmaceuticals' Current Assets stood at $378.3 million in 2022, then increased by 29.41% to $489.6 million in 2023, then rose by 9.08% to $534.1 million in 2024, then advanced by 19.09% to $636.0 million in 2025, then declined by 0.37% to $633.7 million in 2026.
- Business Quant data shows AMPH's Current Assets at $633.7 million in Q1 2026, $636.0 million in Q4 2025, and $639.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.85 Bn | 39.19 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.40 Bn | 29.73 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.42 Bn | 15.03 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 3.22 Bn |
| 10 | Amphastar Pharmaceuticals | 945.33 Mn | 655.21 Mn | 93.47 Mn | 630.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 630.95 Mn |
| Mar 31, 2026 | 633.68 Mn |
| Dec 31, 2025 | 636.02 Mn |
| Sep 30, 2025 | 639.47 Mn |
| Jun 30, 2025 | 580.83 Mn |
| Mar 31, 2025 | 587.96 Mn |
| Dec 31, 2024 | 534.07 Mn |
| Sep 30, 2024 | 545.95 Mn |
| Jun 30, 2024 | 482.65 Mn |
| Mar 31, 2024 | 555.08 Mn |
| Dec 31, 2023 | 489.60 Mn |
| Sep 30, 2023 | 543.01 Mn |
| Jun 30, 2023 | 384.55 Mn |
| Mar 31, 2023 | 407.67 Mn |
| Dec 31, 2022 | 378.32 Mn |
| Sep 30, 2022 | 384.22 Mn |
| Jun 30, 2022 | 377.15 Mn |
| Mar 31, 2022 | 364.42 Mn |
| Dec 31, 2021 | 318.12 Mn |
| Sep 30, 2021 | 303.67 Mn |